Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Sarcoma, Ewing 2Neoplasms 2Breast Neoplasms 2Wilms Tumor 1Triple Negative Breast Neoplasms 1Small Cell Lung Carcinoma 1Sarcoma 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Prostatic Neoplasms 1Pathologic Complete Response 1Pancreatic Neoplasms 1Osteosarcoma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neuroblastoma 1Hepatoblastoma 1Hemangiosarcoma 1Fanconi Anemia, Complementation Group D1 1Carcinoma, Ovarian Epithelial 1

Interventions

Filgrastim 10Cyclophosphamide 8X-Rays 6Phantoms, Imaging 6Granulocyte Colony-Stimulating Factor 6Temozolomide 5Specimen Handling 5Magnetic Resonance Spectroscopy 5Ifosfamide 5Carboplatin 5Vincristine 4Radiotherapy 4Peripheral Blood Stem Cell Transplantation 4Nuclear Medicine Department, Hospital 4Melphalan 4Etoposide 4Busulfan 4Topotecan 3Thiotepa 3Stem Cell Transplantation 3Mesna 3Cisplatin 3Biopsy 3ulixertinib 2tipifarnib 2tazemetostat 2selpercatinib 2sargramostim 2palbociclib 2olaparib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Wilms Tumor × talazoparib × Sarcoma × Clear all
NCT04901702 2026-05-19

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

St. Jude Children's Research Hospital

Phase 1/2 Recruiting
90 enrolled
CNSGastrointestinalGenitourinarySarcoma

Neoplasms, Wilms Tumor, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma, Hepatoblastoma, Neuroectodermal Tumors, Primitive, Peripheral, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡